The presence of CD8+ T cell clones specific for prostate cancer epitopes has been reported among healthy individuals and in early-stage disease, whereas IFN-γ expression in CD8+ T cells from advanced-stage prostate cancer patients tends to be very low or absent.23 Here, IFNG is linked to prostate cancer.